Quantification of α4β2* nicotinic receptors in the rat brain with microPET® and 2-[18F]F-A-85380

NeuroImage

Volumn 34, Issue 4, 2007, Pages 1352-1362

  Vaupel, D Bruce ^a   Stein, Elliot A ^a   Mukhin, Alexey G ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; RADIOLIGAND; UNCLASSIFIED DRUG; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; AZETIDINE DERIVATIVE; FLUORINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BRAIN FUNCTION; BRAIN REGION; BRAIN SCINTISCANNING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; IN VITRO STUDY; LONGITUDINAL STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOACTIVITY; RAT; RECEPTOR OCCUPANCY; STEADY STATE; ANIMAL; BRAIN; IMAGE PROCESSING; KINETICS; METABOLISM; METHODOLOGY; RADIOASSAY; RADIOGRAPHY; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; AZETIDINES; BRAIN; FLUORINE RADIOISOTOPES; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; POSITRON-EMISSION TOMOGRAPHY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 33846808976     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.10.036     Document Type: Article

References (39)

1. 18F-fluoro-A-85380 in healthy volunteers. J. Nucl. Med. 44 (2003) 596-601
2. Brody A.K., Mandelkern M.A., London E.D., Olmstgead R.E., Farahi J., Scheibal D., Jou J., Allen V., Tiongson E., Chefer S.I., Koren A.O., and Mukhin A.G. Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Arch. Gen. Psychiatry 63 (2006) 907-915
3. 18F]-cyclofoxy and positron emission tomography. J. Cereb. Blood Flow Metab. 13 (1993) 24-42
4. 11C]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab. 17 (1997) 437-447
5. 18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48 (2003) 25-34
6. 18F]F-A-85380 under isoflurane and saffan anesthesia. Society for Neuroscience, 33rd Annual Meeting, Washington, DC. Abstract Viewer/Itinerary Planner 683.11.
7. 125I]-α-bungarotoxin. J. Neurosci. 5 (1985) 1307-1315
8. Defrise M., Kinahan P.E., Townsend D.W., Michel C., Sibomana M., and Newport D.F. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans. Med. Imag. 16 (1997) 145-158
9. 18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. Nucl. Med. Biol. 26 (1999) 139-148
10. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. J. Pharmacol. Exp. Ther. 41 (1992) 31-37
11. 11C]rolipram-PET. NeuroImage 26 (2005) 1201-1210
12. 18F-fluoro-A-85380 and PET. J. Nucl. Med. 46 (2005) 240-247
13. Holladay M.W., Dart M.J., and Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40 (1997) 4169-4194
14. 18F]A-85380). J. Labelled Compd. Radiopharm. 41 (1998) 309-318
15. Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., Luthra S.K., Brooks D.J., and Lammertsma A.A. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12 (1992) 47-54
16. Ichise M., Meyer J.H., and Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J. Nucl. Med. 42 (2001) 755-763
17. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 23 (2003) 1096-1112
18. 18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J. 17 (2003) 1331-1333 (electronic publication 2003 May 20)
19. Kimes A.S., Chefer S.I., Matochik J.A., Pavlova O.A., Contoreggi C.S., Horti A.G., Kurian V., Vaupel D.B., Koren A.O., Ernst M., London E.D., and Mukhin A.G. PET quantitation of nicotinic acetylcholine receptors in the human brain. NeuroImage 22 Suppl. 2 (2004) T79
20. Kimes A.S., Chefer S., Contoreggi C.S., Hall A., Horti A., Vaupel D.B., Pavlova O., Stein E.A., and Mukhin A.G. In vivo quantification of the greater densities of alpha4beta2* nicotinic acetylcholine receptors in smokers compared to non-smokers. NeuroImage 31 Suppl. 2 (2006) T153
21. Kimes A.S., Chefer S., Contoreggi C.S., Vaupel D.B., Stein E.A., and Mukhin A.G. Quantification of alpha4beta2* nicotinic acetylcholine receptors in human brain using bolus plus infusion administration of 2-[F-18]F-A-85380. NeuroImage 31 Suppl. 2 (2006) T102
22. Koren A.O., Horti A.G., Mukhin A.G., Gündisch D., Kimes A.S., Dannals R.F., and London E.D. 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J. Med. Chem. 41 (1998) 3690-3698
23. 11C]raclopride studies. J. Cereb. Blood Flow Metab. 16 (1996) 42-52
24. Le Foll B., and Goldberg S.R. Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184 (2006) 367-381
25. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F., and Li Y. Neuronal nicotinic receptor subtypes. Ann. N. Y. Acad. Sci. 757 (1995) 100-116
26. Logan J., Fowler J.S., Volkow N.D., Wang G.-J., Ding Y.-S., and Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16 (1996) 834-840
27. 18F]F-A-85380 PET. Nucl. Med. Biol. 32 (2005) 585-591
28. Molina P.E., Ding Y.-S., Carroll F.I., Liang F., Volkow N.D., Pappas N., Kuhar M., Abumrad N., Gately S.J., and Fowler J.S. Fluro-norchloroepibatidine: preclinical assessment of acute toxicity. Nucl. Med. Biol. 24 (1997) 743-747
29. Mukhin A.G., Gündisch D., Horti A.G., Koren A.O., Tamagnan G., Kimes A.S., Chambers J., Vaupel D.B., King S.L., Picciotto M.R., Innis R.B., and London E.D. 5-Iodo-A-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 57 (2000) 642-649
30. 18F]F-A-85380, a novel PET ligand for α4β2 nicotinic receptors. Society for Neuroscience 30th Annual Meeting, New Orleans, La. Abstr. 26, 627, 235.16.
31. Paxinos G., Huang X.-F., and Toga A.W. The Rhesus Monkey Brain in Stereotaxic Coordinates (2000), Academic Press, New York
32. 18F]F-A85380 for human use. Appl. Radiat. Isot. 63 (2005) 433-435
33. 18F]F-A-85380 parent fraction in blood plasma during PET studies. NeuroImage 31 Suppl. 2 (2006) T54
34. Tai Y.C., Chatziioannou A., Siegel S., Young J., Newport D., Goble R.N., Nutt R.E., and Cherry S.R. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys. Med. Biol. 46 (2001) 1845-1862
35. Turner J.R., and Kellar K.J. Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes. J. Neurosci. 25 (2005) 9258-9265
36. 18F]fluoro-A-85380. J. Nucl. Med. 40 (1999) 1374-1380
37. 18F]fluoro-A-85380: a PET study in monkeys. Synapse 44 (2002) 58-59
38. 123I]5-I-A-85380, a radioligand for in vivo imaging of cerebral neuronal nicotinic acetylcholine receptors in humans. Drug Dev. Res. 58 (2003) 149-168
39. Vaupel D.B., Tella S.R., Huso D.L., Wagner III V.O., Mukhin A.G., Chefer S.I., Horti A.G., London E.D., Koren A.O., and Kimes A.S. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. J. Pharmacol. Exp. Ther. 312 (2005) 355-365 (electronic publication 2004 Aug 26.)